|By Marketwire .||
|July 18, 2012 12:28 PM EDT||
BOULOGNE-BILLANCOURT CEDEX, FRANCE -- (Marketwire) -- 07/18/12 --
CSD and IntrinsiQ Launch Integrated Oncology Data Solution
New Jersey, July 18, 2012 - CSD USA - Cegedim Strategic Data, and IntrinsiQ - an AmerisourceBergen Specialty Group company, today announced their strategic partnership with the launch of an integrated solution for monitoring promotional activity and its impact on Oncology drug utilization in the US market. Available immediately, this new database provides promotional spending combined with actual drug usage data across a significant sample of US Oncologists.
This unique new solution will allow pharmaceutical marketers to utilize real-world treatment data in conjunction with a coordinated set of marketing data. The coordinated data sets provide a "best of breed" solution that overcomes many of the challenges that customers would face from manually combining data from multiple vendors.
CSD's panel of Oncologists has been active since 2006 and provides detailed information on all promotional interactions with pharmaceutical companies including face-to-face and on-line detailing, meetings, advertising and other promotional spending. IntrinsiQ's IntelliView® is the Gold Standard for US real-time, longitudinal Oncology treatment information - sourced from their IntelliDose chemotherapy treatment management solution. The integrated data set tracks activity by tumor-type and empowers users to view promotional activity and impact consistently across the physicians providing therapy for each type of cancer patient.
Both data sets provide projected USA national-level metrics that allow the crossing of treatment information by spending and share of voice. Spending information is available at the channel and subspecialty levels.
Effective with the announcement of their integrated solution, IntrinsiQ becomes the exclusive marketing partner for CSD's enhanced Oncology Data Set in the US. The data set can be accessed from IntrinsiQ's existing customer data portal or through CSD's Analyzer lightweight BI tool.
About Cegedim Strategic Data:
CSD is a leading Market Research company dedicated to the healthcare industry and operating worldwide. With over 40 years experience in the Pharmaceutical industry, CSD offers a comprehensive range of market research services and solutions to its customers, which include more than 50 global and 500 local Pharmaceutical companies. CSD integrates primary and secondary analyses with its medical expertise to meet its customer's research needs.
To learn more, please visit our website: www.cegedimstrategicdata.com
Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, life sciences companies, healthcare professionals and insurance companies. The world leader in life sciences CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs 8,200 people in more than 80 countries and generated revenue of EUR911 million in 2011. Cegedim SA is listed in Paris (EURONEXT: CGM).
To learn more, please visit: www.cegedim.com
IntrinsiQ, a business under AmerisourceBergen Specialty Group's ION Solutions, is the leading provider of medical oncology clinical information systems and the premier source of US-based oncology data and analysis. Each month, IntrinsiQ's clinical software application IntelliDose®, captures the treatment decisions and details from oncologists across the nation creating a database unrivaled in accuracy, detail and timeliness of information about the medical oncology care process. IntelliDose ensure patient safety through automation and standards designed to meet the needs of a specific practice, saving staff time, maximizing reimbursement and reducing operating costs. The system interfaces with leading EMR and hospital information systems, extending existing or planned technology investments to include cancer patient management. For more information, visit: www.intrinsiq.com
CSD and IntrinsiQ Launch Integrated Oncology Solution: http://hugin.info/141732/R/1627691/521000.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: CEGEDIM STRATEGIC DATA via Thomson Reuters ONE [HUG#1627691]